Why Partner with the Premier RNA-Based Therapeutics & Vaccines Summit Asia?
Seize the RNA Boom in Asia & Position Yourself as the Go-To Partner
As RNA therapeutics and vaccines are unlocking potential for emerging infectious diseases, precision oncology, protein replacement and in vivo CART, there is now increasing demand for specialized materials and manufacturing to achieve commercial success for new applications, and Asia is now becoming the go to place for these solutions compared to the USA and Europe based on cost, timelines and quality.
The inaugural RNA-Based Therapeutics & Vaccines Summit Asia is your premium opportunity to align your brand with a targeted audience of key decision-makers and showcase your innovative solutions to a global audience of 80+ RNA experts.
With global biopharma actively forging deals across Asia—including multi-billion-dollar licensing agreements, platform technology collaborations, and CDMO expansions—there has never been a better time to position yourself as the partner of choice and accelerate your commercial objectives in 2025/26.
Experts Are Looking for New Solutions & Services In:
Key Benefits of Partnering:
Position Yourself as the Go-To Service Provider for Asian Companies
While Asia is leading the
charge on novel RNA
innovations, many drug
developers face the same
problem: The need a reliable
service provider to help them
with their RNA R&D and
manufacturing needs on time
Network With Local Industry Experts & Boots-on-the Ground Scientists
Bringing both experts and
newcomers in the same
room, this is your chance
to speed up relationship
building with key decision
makers as well as
scientists that are using
your services daily
Showcase Your
Best-In-Class
Services
Competition in the RNA
industry is fierce, so this is
your opportunity to partner
with a forum to spotlight and
exhibit your services and
cement your position as a key
player in the region
Partnership Opportunities Include:
Who Will You Meet?
